@article{a996a2f6388a48f79e764abc00bbf975,
title = "UltraHigh Field MR Imaging in Epilepsy",
abstract = "More than one million people in the United States suffer from seizures that are not controlled with antiseizure medications. Targeted interventions such as surgery and deep brain stimulation can confer seizure reduction or even freedom in many of these patients with drug-resistant epilepsy, but success critically depends on identification of epileptogenic zones through MR imaging. Ultrahigh field imaging facilitates improved sensitivity and resolution across many imaging modalities and may facilitate better detection of epileptic markers than is achieved at lower field strengths. The increasing availability and clinical adoption of ultrahigh field scanners play an important role in characterizing drug-resistant epilepsy and planning for its treatment.",
keywords = "7T, Epilepsy, MR imaging, Ultrahigh",
author = "Gaurav Verma and Delman, {Bradley N.} and Priti Balchandani",
note = "Funding Information: The authors would like to acknowledge Rebecca Feldman, PhD for her scientific contributions to this chapter. Dr. Priti Balchandani would like to acknowledge funding from the following sources:, NIH-NINDS R00 NS070821/United States, R01 CA202911/CA/NCI NIH HHS/United States, R01 MH109544/MH/NIMH NIH HHS/United States, Dr. Priti Balchandani (the Principal Investigator in this study) is a named inventor on patents relating to magnetic resonance imaging (MRI) and RF pulse design. The patents have been licensed to GE Healthcare, Siemens AG, and Philips international. Dr. Balchandani receives royalty payments relating to these patents. Dr. Balchandani and Dr. Rebecca Feldman are named inventors on patents relating to Slice-selective adiabatic magnetization T2-preparation (SAMPA) for efficient T2-weighted imaging at ultrahigh field strengths, Methods for Producing a Semi-Adiabatic Spectral-Spatial Spectroscopic Imaging Sequence and Devices Thereof, and Semi-Adiabatic Spectral-spatial Spectroscopic Imaging. These patents have been filed through Mount Sinai Innovation Partners; they remain unlicensed, there is no discussion to license them in the near future, and there are consequently no royalties revolving around them. The remaining authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",
year = "2021",
month = feb,
doi = "10.1016/j.mric.2020.09.006",
language = "English",
volume = "29",
pages = "41--52",
journal = "Magnetic Resonance Imaging Clinics of North America",
issn = "1064-9689",
publisher = "W.B. Saunders Ltd",
number = "1",
}